Quantbot Technologies’s Agilon Health AGL Stock Holding History

Quantbot Technologies’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.9K	Sell	242 -3,674	-94%	-$241K	﹤0.01%	1749
2026 Q1	$31K	Buy	3,916 +786	+25%	+$12.7K	﹤0.01%	1463
2025 Q4	$53.9K	Sell	3,130 -11,665	-79%	-$226K	﹤0.01%	1506
2025 Q3	$381K	Buy	+14,795	New	+$559K	0.01%	1121
2024 Q4	–	Sell	-17,732	Closed	-$1.74M	–	1431
2024 Q3	$1.74M	Buy	+17,732	New	+$2.29M	0.07%	439
2024 Q2	–	Sell	-5,651	Closed	-$862K	–	1391
2024 Q1	$862K	Buy	+5,651	New	+$940K	0.05%	568
2023 Q3	–	Sell	-541	Closed	-$234K	–	1499
2023 Q2	$234K	Sell	541 -1,308	-71%	-$735K	0.02%	921
2023 Q1	$1.1M	Buy	+1,849	New	+$1.04M	0.08%	376
2021 Q4	–	Sell	-710	Closed	-$465K	–	1453
2021 Q3	$465K	Buy	710 +679	+2,190%	+$580K	0.03%	626
2021 Q2	$31K	Buy	+31	New	+$27.2K	﹤0.01%	1156

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Quantbot Technologies's AGL Position: Q2 2026 in Review

Quantbot Technologies reduced its Agilon Health (AGL) stake by 94% in Q2 2026, selling an estimated $241K and leaving 242 shares worth $25.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1749.

Quantbot Technologies first reported a position in AGL in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.74M in Q3 2024. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

Quantbot Technologies held 242 shares of Agilon Health worth $25.9K as of Q2 2026.
Quantbot Technologies sold 3,674 Agilon Health shares in Q2 2026, an estimated $241K.
Agilon Health made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1749 holding.
Quantbot Technologies first reported a position in Agilon Health in Q2 2021 and has held it in 10 quarters since.
Quantbot Technologies's Agilon Health position peaked at $1.74M in Q3 2024.
179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.